B2M and breast carcinoma: These results suggest that β2M overexpression downregulates p-CREB/CREB and VEGF levels and significantly upregulates p-ERK/ERK levels, but does not affect HIF-1α protein and p-SGK1/SGK1 levels in the cell lines of ER− breast cancer with HER2−.